Evidence map›Paper›PMID 31068208›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.

Hsin-Ling Yang, Varadharajan Thiyagarajan, Pei-Chun Shen, Dony Chacko Mathew, Kai-Yuan Lin, Jiunn-Wang Liao, You-Cheng Hseu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 142 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification of dynamic network biomarkerMolecular therapy. Oncology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hsin-Ling YangInstitute of Nutrition, College of Biopharmaceuticals and Food Sciences, China Medical University, Taichung, 40402, Taiwan.
Varadharajan ThiyagarajanDepartment of Cosmeceutics, College of Biopharmaceutical and Food Sciences, China Medical University, No. 91, Hsueh-Shih Road, Taichung, 40402, Taiwan.
Pei-Chun ShenInstitute of Nutrition, College of Biopharmaceuticals and Food Sciences, China Medical University, Taichung, 40402, Taiwan.
Dony Chacko MathewInstitute of Nutrition, College of Biopharmaceuticals and Food Sciences, China Medical University, Taichung, 40402, Taiwan.
Kai-Yuan LinDepartment of Medical Research, Chi-Mei Medical Center, Tainan, 710, Taiwan.
Jiunn-Wang LiaoGraduate Institute of Veterinary Pathology, National Chung Hsing University, Taichung, 40227, Taiwan.
You-Cheng HseuDepartment of Cosmeceutics, College of Biopharmaceutical and Food Sciences, China Medical University, No. 91, Hsueh-Shih Road, Taichung, 40402, Taiwan. ychseu@mail.cmu.edu.tw.
China Medical University · TWAsia University · TWChi Mei Medical Center · TWNational Chung Hsing University · TW

Funding

Ministry of Education CMRC-CHM-9Ministry of Science and Technology, Taiwan CMU 107-S-47Ministry of Science and Technology, Taiwan MOST-106-2320-B-039-054-MY3Ministry of Science and Technology, Taiwan MOST-107-2320-B-039-013-MY3
6 · The paper itself

Abstract

backgroundBreast cancer is the most prevalent cancer among women. In triple-negative breast cancer (TNBC) cells, a novel quinone derivative, coenzyme Q

methodsInvasion, as well as MTT assays were conducted. Lipofectamine RNAiMAX was used to transfect cells with β-catenin siRNA. Through Western blotting and RT-PCR, the major signaling pathways' protein expressions were examined, and the biopsied tumor tissues underwent immunohistochemical and hematoxylin and eosin staining as well as Western blotting.

resultsCoQ

conclusionsCoQ

Indexed as

AnimalsAntigens, CDApoptosisbeta CateninCadherinsCell Cycle CheckpointsCell MovementCell ProliferationEpithelial-Mesenchymal TransitionHumansMatrix Metalloproteinase 9MiceNeoplasm InvasivenessNeoplasm MetastasisNF-kappa BPhosphatidylinositol 3-KinasesAntigens, CDbeta CateninCadherinsCDH1 protein, humanMatrix Metalloproteinase 9NF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesRNA, Small InterferingUbiquinoneCoQ0EMTHuman epidermal growth factor receptor 2MetastasisROSTGF-β1TNBC

Identifiers

PMID31068208
PMCPMC6505074
OpenAlexW2946899700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.